Warberg Asset Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,766	Closed	-$78.2K	–	246
2023 Q1	$78.2K	Sell	17,766 -19,271	-52%	-$84.8K	0.02%	102
2022 Q4	$219K	Buy	+37,037	New	+$219K	0.03%	78